To the Editor: A 23-year-old woman presented to the emergency department with bilateral pain, swelling and loss of power in her upper arms, which had started that morning. She had no history of significant trauma. Her medical history was significant for Wolff–Parkinson–White syndrome, diagnosed 3 weeks earlier at the same institution, and mild depression, diagnosed 8 months earlier, for which she had been taking desvenlafaxine (50 mg daily for the first 4 months, and then 100 mg daily until her presentation). She had no known adverse drug reactions.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-245.
- 2. Jewell DP, Thompson IW, Sullivan BA, Bondeson J. Reversible focal myositis in a patient taking venlafaxine. Rheumatology (Oxford) 2004; 43: 1590-1593.
- 3. Oliver JJ, Kelly C, Jarvie D, et al. Venlafaxine poisoning complicated by a late rise in creatinine kinase: two case reports. Hum Exp Toxicol 2002; 21: 463-466.
- 4. Pascale P, Oddo M, Pacher P, et al. Severe rhabdomyolysis following venlafaxine overdose. Ther Drug Monit 2005; 27: 562-564.
No relevant disclosures.